Condensed Consolidated Statements of Operations (USD $)	3 Months Ended		6 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2012	Dec. 31, 2011
REVENUES	$ 46,249	$ 1,043	$ 48,043	$ 2,224
COST OF SALES		233		1,692
GROSS MARGIN	46,249	810	48,043	532
Research and development	15,506	30,643	23,950	48,360
Depreciation and amortization	185	174	364	358
Bad debt expense				203
General and administrative	536,309	273,772	725,138	512,451
Total Operating Expenses	552,000	304,589	749,452	561,372
OPERATING LOSS	(505,751)	(303,779)	665,579	(560,840)
Interest expense	(238)		(476)
Other income	5,585	917	5,585	3,124
Total Other Income (Expense)	5,347	917	5,109	3,124
Loss before income taxes and noncontrolling interest	(500,404)	(302,862)	(696,300)	(557,716)
NET INCOME (LOSS)	(500,404)	(302,862)	(696,300)	(557,716)
Less: Net loss attributable to noncontrolling interest	(15,030)	(18,417)	(30,721)	(35,677)
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS	(485,374)	(284,445)	(665,579)	(522,039)
Foreign currency translation adjustments	32,899	40,114	35,687	47,131
Total Other Comprehensive Income (Loss)	32,899	40,114	35,687	47,131
COMPREHENSIVE LOSS	$ (467,505)	$ (262,748)	$ (660,613)	$ (510,585)
BASIC AND DILUTED LOSS PER SHARE	$ 0.00	$ 0.00	$ (0.01)	$ 0.00
BASIC AND DILUTED WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING	126,219,007	113,885,135	126,219,007	113,885,135